000917405 001__ 917405
000917405 005__ 20240201205520.0
000917405 0247_ $$2doi$$a10.1111/jnc.15598
000917405 0247_ $$2ISSN$$a0022-3042
000917405 0247_ $$2ISSN$$a1471-4159
000917405 0247_ $$2Handle$$a2128/34036
000917405 0247_ $$2pmid$$a35226362
000917405 0247_ $$2WOS$$aWOS:000782554700001
000917405 037__ $$aFZJ-2023-00619
000917405 082__ $$a610
000917405 1001_ $$0P:(DE-Juel1)178642$$aHoenig, Merle C.$$b0$$eCorresponding author
000917405 245__ $$aClear‐headed into old age: Resilience and resistance against brain aging—A PET imaging perspective
000917405 260__ $$aOxford$$bWiley-Blackwell$$c2023
000917405 3367_ $$2DataCite$$aOutput Types/Book Review
000917405 3367_ $$0PUB:(DE-HGF)36$$2PUB:(DE-HGF)$$aReview$$breview$$mreview$$s1706773609_9136
000917405 3367_ $$2ORCID$$aBOOK_REVIEW
000917405 3367_ $$2DRIVER$$areview
000917405 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000917405 3367_ $$2BibTeX$$aARTICLE
000917405 3367_ $$00$$2EndNote$$aJournal Article
000917405 520__ $$aWith the advances in modern medicine and the adaptation towards healthier lifestyles, the average life expectancy has doubled since the 1930s, with individuals born in the millennium years now carrying an estimated life expectancy of around 100 years. And even though many individuals around the globe manage to age successfully, the prevalence of aging-associated neurodegenerative diseases such as sporadic Alzheimer’s disease has never been as high as nowadays. The prevalence of Alzheimer’s disease is anticipated to triple by 2050, increasing the societal and economic burden tremendously. Despite all efforts, there is still no available treatment defeating the accelerated aging process as seen in this disease. Yet, given the advances in neuroimaging techniques that are discussed in the current Review article, such as in positron emission tomography (PET) or magnetic resonance imaging (MRI), pivotal insights into the heterogenous effects of aging-associated processes and the contribution of distinct lifestyle and risk factors already have and are still being gathered. In particular, the concepts of resilience (i.e. coping with brain pathology) and resistance (i.e. avoiding brain pathology) have more recently been discussed as they relate to mechanisms that are associated with the prolongation and/or even stop of the progressive brain aging process. Better understanding of the underlying mechanisms of resilience and resistance may one day, hopefully, support the identification of defeating mechanism against accelerating aging.
000917405 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000917405 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x1
000917405 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000917405 7001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b1$$ufzj
000917405 773__ $$0PERI:(DE-600)2020528-4$$a10.1111/jnc.15598$$gp. jnc.15598$$n3$$p325-345$$tJournal of neurochemistry$$v164$$x0022-3042$$y2023
000917405 8564_ $$uhttps://juser.fz-juelich.de/record/917405/files/Journal%20of%20Neurochemistry%20-%202022%20-%20Hoenig%20-%20Clear%E2%80%90headed%20into%20old%20age%20Resilience%20and%20resistance%20against%20brain%20aging%20A%20PET.pdf$$yOpenAccess
000917405 909CO $$ooai:juser.fz-juelich.de:917405$$pdriver$$pVDB$$pdnbdelivery$$popenaire$$popen_access
000917405 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)178642$$aForschungszentrum Jülich$$b0$$kFZJ
000917405 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b1$$kFZJ
000917405 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000917405 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x1
000917405 9141_ $$y2023
000917405 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-18
000917405 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-18
000917405 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000917405 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2022-11-18$$wger
000917405 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-18
000917405 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000917405 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-08-19$$wger
000917405 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROCHEM : 2022$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-19
000917405 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-19
000917405 920__ $$lyes
000917405 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000917405 980__ $$areview
000917405 980__ $$aVDB
000917405 980__ $$ajournal
000917405 980__ $$aI:(DE-Juel1)INM-2-20090406
000917405 980__ $$aUNRESTRICTED
000917405 9801_ $$aFullTexts